Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2026-01-07 @ 10:36 AM
Study NCT ID:
NCT02130193
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2013-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-13
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-29
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-19
First Submit QC Date:
None
Study First Post Date:
2014-05-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-04
Results First Submit QC Date:
None
Results First Post Date:
2017-05-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-13
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL